452 related articles for article (PubMed ID: 26765786)
21. γ-Cyclodextrin.
Saokham P; Loftsson T
Int J Pharm; 2017 Jan; 516(1-2):278-292. PubMed ID: 27989822
[TBL] [Abstract][Full Text] [Related]
22. Development of thermosensitive poloxamer 407-based microbubble gel with ultrasound mediation for inner ear drug delivery.
Liao AH; Shih CP; Li MW; Lin YC; Chuang HC; Wang CH
Drug Deliv; 2021 Dec; 28(1):1256-1271. PubMed ID: 34142922
[TBL] [Abstract][Full Text] [Related]
23. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.
Jansook P; Fülöp Z; Ritthidej GC
Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399
[TBL] [Abstract][Full Text] [Related]
24. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
Jansook P; Stefánsson E; Thorsteinsdóttir M; Sigurdsson BB; Kristjánsdóttir SS; Bas JF; Sigurdsson HH; Loftsson T
Eur J Pharm Biopharm; 2010 Oct; 76(2):208-14. PubMed ID: 20637867
[TBL] [Abstract][Full Text] [Related]
25. A novel formulation of solubilised amphotericin B designed for ophthalmic use.
Serrano DR; Ruiz-Saldaña HK; Molero G; Ballesteros MP; Torrado JJ
Int J Pharm; 2012 Nov; 437(1-2):80-2. PubMed ID: 22890190
[TBL] [Abstract][Full Text] [Related]
26. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity.
Jones DS; Bruschi ML; de Freitas O; Gremião MP; Lara EH; Andrews GP
Int J Pharm; 2009 May; 372(1-2):49-58. PubMed ID: 19429268
[TBL] [Abstract][Full Text] [Related]
27. The self-assemble of natural cyclodextrins in aqueous solutions: Application of miniature permeation studies for critical aggregation concentration (cac) determinations.
Saokham P; Sá Couto A; Ryzhakov A; Loftsson T
Int J Pharm; 2016 May; 505(1-2):187-93. PubMed ID: 27021466
[TBL] [Abstract][Full Text] [Related]
28. Latanoprost-loaded cyclodextrin microaggregate suspension eye drops for enhanced bioavailability and stability.
Zhou X; Li X; Xu J; Cheng Y; Cao F
Eur J Pharm Sci; 2021 May; 160():105758. PubMed ID: 33588044
[TBL] [Abstract][Full Text] [Related]
29. Cyclodextrin-based telmisartan ophthalmic suspension: Formulation development for water-insoluble drugs.
Muankaew C; Jansook P; Sigurđsson HH; Loftsson T
Int J Pharm; 2016 Jun; 507(1-2):21-31. PubMed ID: 27139144
[TBL] [Abstract][Full Text] [Related]
30. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle.
Sherif S; Bendas ER; Badawy S
Eur J Pharm Biopharm; 2014 Feb; 86(2):251-9. PubMed ID: 24056055
[TBL] [Abstract][Full Text] [Related]
31. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system.
Cao F; Zhang X; Ping Q
Drug Deliv; 2010; 17(7):500-7. PubMed ID: 20500130
[TBL] [Abstract][Full Text] [Related]
32. Aqueous eye drops containing drug/cyclodextrin nanoparticles deliver therapeutic drug concentrations to both anterior and posterior segment.
Loftsson T; Stefánsson E
Acta Ophthalmol; 2022 Feb; 100(1):7-25. PubMed ID: 33876553
[TBL] [Abstract][Full Text] [Related]
33. Injectable Poloxamer Hydrogel Formulations for Intratympanic Delivery of Dexamethasone.
Le TP; Yu Y; Cho IS; Suh EY; Kwon HC; Shin SA; Park YH; Huh KM
J Korean Med Sci; 2023 May; 38(17):e135. PubMed ID: 37128878
[TBL] [Abstract][Full Text] [Related]
34. New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp.
Ruiz HK; Serrano DR; Dea-Ayuela MA; Bilbao-Ramos PE; Bolás-Fernández F; Torrado JJ; Molero G
Int J Pharm; 2014 Oct; 473(1-2):148-57. PubMed ID: 24998510
[TBL] [Abstract][Full Text] [Related]
35. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans.
Kristinsson JK; Fridriksdóttir H; Thórisdóttir S; Sigurdardóttir AM; Stefánsson E; Loftsson T
Invest Ophthalmol Vis Sci; 1996 May; 37(6):1199-203. PubMed ID: 8631635
[TBL] [Abstract][Full Text] [Related]
36. Interaction of Native Cyclodextrins and Their Hydroxypropylated Derivatives with Carbamazepine in Aqueous Solution. Evaluation of Inclusion Complexes and Aggregates Formation.
Rodrigues Sá Couto A; Ryzhakov A; Larsen KL; Loftsson T
ACS Omega; 2019 Jan; 4(1):1460-1469. PubMed ID: 31459413
[TBL] [Abstract][Full Text] [Related]
37. Chemical modification of hydrophobic block in poly(ethylene oxide) poly(caprolactone) based nanocarriers: effect on the solubilization and hemolytic activity of amphotericin B.
Falamarzian A; Lavasanifar A
Macromol Biosci; 2010 Jun; 10(6):648-56. PubMed ID: 20352627
[TBL] [Abstract][Full Text] [Related]
38. Direct electrospinning for producing multiple activity nanofibers consisting of aggregated luteolin/hydroxypropyl-gamma-cyclodextrin inclusion complex.
Feng W; Guo X; Yang G; Yao Y; Zhao L; Gao S; Ye F; Fu Y
Int J Biol Macromol; 2024 Jun; 270(Pt 1):132344. PubMed ID: 38754666
[TBL] [Abstract][Full Text] [Related]
39. Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles.
Kupetz E; Bunjes H
J Control Release; 2014 Sep; 189():54-64. PubMed ID: 24933601
[TBL] [Abstract][Full Text] [Related]
40.
Hemelryck SV; Dewulf J; Niekus H; van Heerden M; Ingelse B; Holm R; Mannaert E; Langguth P
Int J Pharm X; 2019 Dec; 1():100016. PubMed ID: 31517281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
